NCT07591818

Brief Summary

A review of the sports medicine literature reveals a clear underrepresentation of female athletes in research. In the current era of precision medicine, increasing attention has been directed toward the regulatory roles of estrogen and progesterone in athletic performance and health optimization. Regular fluctuations in estrogen and progesterone across menstrual cycle phases (i.e., early follicular, late follicular, and mid-luteal phases) may influence strength performance, hydration status, body composition, and energy balance. However, few studies have examined these outcomes using hormonal confirmation of menstrual cycle phases. Monophasic oral contraceptive use also represents a highly relevant hormonal condition among female athletes, as exogenous hormones suppress endogenous ovarian fluctuations and create distinct hormonal profiles across active pill-consumption and withdrawal phases. Nevertheless, the influence of oral contraceptive phases on strength-related outcomes, hydration markers, body water regulation, body composition, and energy balance remains insufficiently characterized, particularly in comparison with naturally menstruating athletes. In response to these gaps, this longitudinal observational study primarily aims to examine variations in strength-related outcomes across three distinct menstrual cycle phases (early follicular, late follicular, and mid-luteal) in eumenorrheic athletes. Secondary objectives include: (i) conducting within- and between-group comparisons of hydration status, energy balance, and strength outcomes (maximal, endurance, and explosive torque) in naturally menstruating athletes and oral contraceptive users; (ii) testing the reliability of methods used to assess body water, energy expenditure, and body composition across the menstrual cycle; (iii) exploring associations between energy availability, resting energy expenditure, and sex hormone concentrations across menstrual cycle phases; and (iv) testing, validating, and proposing methodological recommendations for the use of bioelectrical impedance analysis in tracking fluid-related changes across hormonal phases. To achieve these goals, the study will use a longitudinal observational design involving 40 female athletes, including 24 naturally menstruating athletes and 16 oral contraceptive users. Naturally menstruating athletes will be assessed during the early follicular, late follicular, and mid-luteal phases of the menstrual cycle, while oral contraceptive users will be assessed across pill-consumption and withdrawal phases. Measurements will be conducted across the three menstrual cycle phases and across oral contraceptive use phases, and will include: i) maximal voluntary isometric strength assessed using handgrip dynamometry, bench press, and leg press; ii) serum estrogen and progesterone; iii) body water and its compartments, and water turnover by dilution techniques; iv) hydration status by plasma osmolality, sodium, and vasopressin; v) energy balance by doubly labeled water and body composition changes; vi) resting energy expenditure by indirect calorimetry.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
24mo left

Started Apr 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Apr 2026Jun 2028

Study Start

First participant enrolled

April 1, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 11, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 18, 2026

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

May 18, 2026

Status Verified

May 1, 2026

Enrollment Period

1.7 years

First QC Date

May 11, 2026

Last Update Submit

May 11, 2026

Conditions

Keywords

Muscle StrengthSex HormonesFluid BalanceEnergy ExpenditureBody Composition

Outcome Measures

Primary Outcomes (4)

  • Maximal Strength

    Upper- and lower-body maximal strength will be assessed during the three evaluation periods using maximal voluntary isometric contractions performed on a bench press machine and a horizontal leg press, respectively. For each exercise, participants will perform three 5-second maximal voluntary isometric contractions, with 1-minute rest intervals between trials. All contractions will be executed isometrically, without joint movement. Maximal strength will be defined as the highest peak force value obtained during the maximal voluntary isometric contraction trials.

    4 weeks

  • Explosive Strength

    Explosive strength of the upper and lower limbs will be assessed by analysing the rate of force development derived from the force-time curve obtained during maximal voluntary isometric contractions performed on a bench press machine (upper limbs) and a horizontal leg press (lower limbs). The rate of force development will be calculated as the slope of the force-time curve (Δforce/Δtime) and expressed in newtons per second (N/s). Peak rate of force development will be identified as the maximum slope of the force-time curve using a 20-millisecond sliding window. Sequential rate of force development will be computed over consecutive 50-millisecond intervals from contraction onset (0 ms) up to 250 ms. Values at 50, 100, 150, 200, and 250 ms will be reported in both absolute terms and normalised to maximal voluntary isometric contraction force, as previously described.

    4 weeks

  • Endurance Strength

    Muscular endurance will be assessed for both upper and lower limbs using a bench press machine and a horizontal leg press, respectively. Participants will perform a sustained isometric contraction at 40% of their maximal voluntary isometric contraction force until task failure. Task failure will be defined as a force decline exceeding 10% below the target level (40% of maximal voluntary isometric contraction) sustained for more than 10 seconds. Standardised verbal encouragement and real-time visual feedback will be provided throughout the test.

    4 weeks

  • Handgrip strength

    Handgrip strength will be measured as the maximal voluntary isometric contraction of the hand and forearm muscles using a portable hand dynamometer (JAMAR Plus+, Patterson Medical, USA). Participants will be assessed in a standing position with the arm in a neutral position (midway between supination and pronation) and the elbow fully extended alongside the body. Prior to testing, the dynamometer handle will be adjusted to each participant's hand size. Measurements will be performed alternately on both hands until three valid attempts are completed for each hand. For each attempt, the participant will exert maximal grip force for 5 seconds, followed by a 60-second rest interval.

    4 weeks

Secondary Outcomes (27)

  • Menstrual cycle determination

    4 weeks

  • Total Body Water

    4 weeks

  • Extracellular Water

    4 weeks

  • Intracellular Water

    4 weeks

  • Water Balance/Turnover

    4 weeks

  • +22 more secondary outcomes

Study Arms (2)

Naturally Menstruating Group

Female athletes with regular ovulatory menstrual cycles (21-35 days, ≥9 cycles/year) who are not using hormonal contraceptives. Participants will be evaluated prospectively during three confirmed menstrual cycle phases: early follicular, late follicular, and mid-luteal. No intervention will be applied.

Oral Contraceptive (OC) Users Group

Female athletes who have been using a combined monophasic 21-day oral contraceptive for at least three months prior to enrollment. Participants will be prospectively evaluated during both the active pill phase (week 1 and week 2-3) and the withdrawal phase (week 4). No intervention will be applied.

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsCisgender female individuals (biologically born female individuals not currently under gender-transition therapy)
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

The study population will consist of 40 female athletes aged 18 to 30 years. Participants will be recruited through Portuguese sports federations and the Portuguese Commission of Olympic Athletes. All participants will be classified as at least Tier 2 athletes with a minimum of one year of federated sports participation. Participants will be allocated into two groups according to menstrual and hormonal status:i) Natural menstrual cycle group (n = 24); ii) Oral contraceptive users group (n = 16). All participants will be cisgender women, biologically female, and not undergoing gender-transition therapy.

You may qualify if:

  • Cisgender female individuals (biologically female, not undergoing gender-transition therapy)
  • Age between 18 and 30 years;
  • Classified as at least Tier 2 athletes;
  • Minimum of 1 year of federated sports participation;
  • Menarche occurred at least 3 years prior to enrollment;
  • Menstrual cycle length between 21 and 35 days with at least nine consecutive cycles in the previous year;
  • Confirmed ovulatory cycle (luteinizing hormone surge and progesterone \>16 nmol/L);
  • Use of combined monophasic oral contraceptives with a 21-day regimen;
  • Use of the same oral contraceptive for at least 3 months prior to enrollment;

You may not qualify if:

  • Pregnancy or child birth within the previous 12 months;
  • Active smoking;
  • Diagnosis of metabolic, cardiovascular, or respiratory disease:
  • Use of continuous or extended-cycle oral contraceptives.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculdade de Motricidade Humana

Cruz Quebrada, Oeiras, 1495-751, Portugal

RECRUITING

Related Publications (40)

  • World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053. No abstract available.

    PMID: 24141714BACKGROUND
  • Dam TV, Dalgaard LB, Sevdalis V, Bibby BM, Janse DE Jonge X, Gravholt CH, Hansen M. Muscle Performance during the Menstrual Cycle Correlates with Psychological Well-Being, but Not Fluctuations in Sex Hormones. Med Sci Sports Exerc. 2022 Oct 1;54(10):1678-1689. doi: 10.1249/MSS.0000000000002961.

    PMID: 36106832BACKGROUND
  • Guyatt GH, Townsend M, Berman LB, Keller JL. A comparison of Likert and visual analogue scales for measuring change in function. J Chronic Dis. 1987;40(12):1129-33. doi: 10.1016/0021-9681(87)90080-4.

    PMID: 3680471BACKGROUND
  • Florez CM, Rodriguez C, Siedler MR, Tinoco E, Tinsley GM. Body composition estimation from mobile phone three-dimensional imaging: evaluation of the USA army one-site method. Br J Nutr. 2024 Oct 16;132(9):1-9. doi: 10.1017/S0007114524002216. Online ahead of print.

    PMID: 39411840BACKGROUND
  • Heymsfield SB, Wang J, Lichtman S, Kamen Y, Kehayias J, Pierson RN Jr. Body composition in elderly subjects: a critical appraisal of clinical methodology. Am J Clin Nutr. 1989 Nov;50(5 Suppl):1167-75; discussion 1231-5. doi: 10.1093/ajcn/50.5.1167.

    PMID: 2683725BACKGROUND
  • Wang Z, Pi-Sunyer FX, Kotler DP, Wielopolski L, Withers RT, Pierson RN Jr, Heymsfield SB. Multicomponent methods: evaluation of new and traditional soft tissue mineral models by in vivo neutron activation analysis. Am J Clin Nutr. 2002 Nov;76(5):968-74. doi: 10.1093/ajcn/76.5.968.

    PMID: 12399267BACKGROUND
  • Sagayama H, Yamada Y, Racine NM, Shriver TC, Schoeller DA; DLW Study Group. Dilution space ratio of 2H and 18O of doubly labeled water method in humans. J Appl Physiol (1985). 2016 Jun 1;120(11):1349-54. doi: 10.1152/japplphysiol.01037.2015. Epub 2016 Mar 17.

    PMID: 26989221BACKGROUND
  • Matias CN, Santos DA, Judice PB, Magalhaes JP, Minderico CS, Fields DA, Lukaski HC, Sardinha LB, Silva AM. Estimation of total body water and extracellular water with bioimpedance in athletes: A need for athlete-specific prediction models. Clin Nutr. 2016 Apr;35(2):468-474. doi: 10.1016/j.clnu.2015.03.013. Epub 2015 Mar 28.

    PMID: 25886709BACKGROUND
  • Rosenbaum M, Ravussin E, Matthews DE, Gilker C, Ferraro R, Heymsfield SB, Hirsch J, Leibel RL. A comparative study of different means of assessing long-term energy expenditure in humans. Am J Physiol. 1996 Mar;270(3 Pt 2):R496-504. doi: 10.1152/ajpregu.1996.270.3.R496.

    PMID: 8780213BACKGROUND
  • WEIR JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol. 1949 Aug;109(1-2):1-9. doi: 10.1113/jphysiol.1949.sp004363. No abstract available.

    PMID: 15394301BACKGROUND
  • Jesus F, Sousa M, Nunes CL, Francisco R, Rocha P, Minderico CS, Sardinha LB, Silva AM. Energy Availability Over One Athletic Season: An Observational Study Among Athletes From Different Sports. Int J Sport Nutr Exerc Metab. 2022 Jul 13;32(6):479-490. doi: 10.1123/ijsnem.2022-0039. Print 2022 Nov 1.

    PMID: 35894910BACKGROUND
  • Rodriguez-Rosell D, Pareja-Blanco F, Aagaard P, Gonzalez-Badillo JJ. Physiological and methodological aspects of rate of force development assessment in human skeletal muscle. Clin Physiol Funct Imaging. 2018 Sep;38(5):743-762. doi: 10.1111/cpf.12495. Epub 2017 Dec 20.

    PMID: 29266685BACKGROUND
  • Maffiuletti NA, Aagaard P, Blazevich AJ, Folland J, Tillin N, Duchateau J. Rate of force development: physiological and methodological considerations. Eur J Appl Physiol. 2016 Jun;116(6):1091-116. doi: 10.1007/s00421-016-3346-6. Epub 2016 Mar 3.

    PMID: 26941023BACKGROUND
  • McKay AKA, Stellingwerff T, Smith ES, Martin DT, Mujika I, Goosey-Tolfrey VL, Sheppard J, Burke LM. Defining Training and Performance Caliber: A Participant Classification Framework. Int J Sports Physiol Perform. 2022 Feb 1;17(2):317-331. doi: 10.1123/ijspp.2021-0451. Epub 2022 Dec 29.

    PMID: 34965513BACKGROUND
  • Meignie A, Duclos M, Carling C, Orhant E, Provost P, Toussaint JF, Antero J. The Effects of Menstrual Cycle Phase on Elite Athlete Performance: A Critical and Systematic Review. Front Physiol. 2021 May 19;12:654585. doi: 10.3389/fphys.2021.654585. eCollection 2021.

    PMID: 34093223BACKGROUND
  • Matias CN, Judice PB, Santos DA, Magalhaes JP, Minderico CS, Fields DA, Sardinha LB, Silva AM. Suitability of Bioelectrical Based Methods to Assess Water Compartments in Recreational and Elite Athletes. J Am Coll Nutr. 2016 Jul;35(5):413-21. doi: 10.1080/07315724.2015.1058198. Epub 2016 Mar 2.

    PMID: 26934568BACKGROUND
  • Campa F, Matias CN, Marini E, Heymsfield SB, Toselli S, Sardinha LB, Silva AM. Identifying Athlete Body Fluid Changes During a Competitive Season With Bioelectrical Impedance Vector Analysis. Int J Sports Physiol Perform. 2020 Mar 1;15(3):361-367. doi: 10.1123/ijspp.2019-0285.

    PMID: 31188697BACKGROUND
  • Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gomez J, Lilienthal Heitmann B, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, M W J Schols A, Pichard C; ESPEN. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr. 2004 Dec;23(6):1430-53. doi: 10.1016/j.clnu.2004.09.012.

    PMID: 15556267BACKGROUND
  • Silva AM, Matias CN, Santos DA, Rocha PM, Minderico CS, Sardinha LB. Increases in intracellular water explain strength and power improvements over a season. Int J Sports Med. 2014 Dec;35(13):1101-5. doi: 10.1055/s-0034-1371839. Epub 2014 Jul 10.

    PMID: 25009970BACKGROUND
  • Cheuvront SN, Kenefick RW. Dehydration: physiology, assessment, and performance effects. Compr Physiol. 2014 Jan;4(1):257-85. doi: 10.1002/cphy.c130017.

    PMID: 24692140BACKGROUND
  • Sims ST, Kerksick CM, Smith-Ryan AE, Janse de Jonge XAK, Hirsch KR, Arent SM, Hewlings SJ, Kleiner SM, Bustillo E, Tartar JL, Starratt VG, Kreider RB, Greenwalt C, Renteria LI, Ormsbee MJ, VanDusseldorp TA, Campbell BI, Kalman DS, Antonio J. International society of sports nutrition position stand: nutritional concerns of the female athlete. J Int Soc Sports Nutr. 2023 Dec;20(1):2204066. doi: 10.1080/15502783.2023.2204066.

    PMID: 37221858BACKGROUND
  • Stachenfeld NS. Sex hormone effects on body fluid regulation. Exerc Sport Sci Rev. 2008 Jul;36(3):152-9. doi: 10.1097/JES.0b013e31817be928.

    PMID: 18580296BACKGROUND
  • Oxfeldt M, Phillips SM, Andersen OE, Johansen FT, Bangshaab M, Risikesan J, McKendry J, Melin AK, Hansen M. Low energy availability reduces myofibrillar and sarcoplasmic muscle protein synthesis in trained females. J Physiol. 2023 Aug;601(16):3481-3497. doi: 10.1113/JP284967. Epub 2023 Jun 29.

    PMID: 37329147BACKGROUND
  • Mountjoy M, Ackerman KE, Bailey DM, Burke LM, Constantini N, Hackney AC, Heikura IA, Melin A, Pensgaard AM, Stellingwerff T, Sundgot-Borgen JK, Torstveit MK, Jacobsen AU, Verhagen E, Budgett R, Engebretsen L, Erdener U. 2023 International Olympic Committee's (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). Br J Sports Med. 2023 Sep;57(17):1073-1097. doi: 10.1136/bjsports-2023-106994.

    PMID: 37752011BACKGROUND
  • Giersch GEW, Charkoudian N, Stearns RL, Casa DJ. Fluid Balance and Hydration Considerations for Women: Review and Future Directions. Sports Med. 2020 Feb;50(2):253-261. doi: 10.1007/s40279-019-01206-6.

    PMID: 31641955BACKGROUND
  • Dasa MS, Kristoffersen M, Ersvaer E, Bovim LP, Bjorkhaug L, Moe-Nilssen R, Sagen JV, Haukenes I. The Female Menstrual Cycles Effect on Strength and Power Parameters in High-Level Female Team Athletes. Front Physiol. 2021 Feb 22;12:600668. doi: 10.3389/fphys.2021.600668. eCollection 2021.

    PMID: 33692699BACKGROUND
  • Niering M, Wolf-Belala N, Seifert J, Tovar O, Coldewey J, Kuranda J, Muehlbauer T. The Influence of Menstrual Cycle Phases on Maximal Strength Performance in Healthy Female Adults: A Systematic Review with Meta-Analysis. Sports (Basel). 2024 Jan 12;12(1):31. doi: 10.3390/sports12010031.

    PMID: 38251305BACKGROUND
  • Sung E, Han A, Hinrichs T, Vorgerd M, Manchado C, Platen P. Effects of follicular versus luteal phase-based strength training in young women. Springerplus. 2014 Nov 11;3:668. doi: 10.1186/2193-1801-3-668. eCollection 2014.

    PMID: 25485203BACKGROUND
  • Blagrove RC, Bruinvels G, Pedlar CR. Variations in strength-related measures during the menstrual cycle in eumenorrheic women: A systematic review and meta-analysis. J Sci Med Sport. 2020 Dec;23(12):1220-1227. doi: 10.1016/j.jsams.2020.04.022. Epub 2020 May 17.

    PMID: 32456980BACKGROUND
  • Thompson B, Almarjawi A, Sculley D, Janse de Jonge X. The Effect of the Menstrual Cycle and Oral Contraceptives on Acute Responses and Chronic Adaptations to Resistance Training: A Systematic Review of the Literature. Sports Med. 2020 Jan;50(1):171-185. doi: 10.1007/s40279-019-01219-1.

    PMID: 31677121BACKGROUND
  • Colenso-Semple LM, D'Souza AC, Elliott-Sale KJ, Phillips SM. Current evidence shows no influence of women's menstrual cycle phase on acute strength performance or adaptations to resistance exercise training. Front Sports Act Living. 2023 Mar 23;5:1054542. doi: 10.3389/fspor.2023.1054542. eCollection 2023.

    PMID: 37033884BACKGROUND
  • Suchomel TJ, Nimphius S, Bellon CR, Stone MH. The Importance of Muscular Strength: Training Considerations. Sports Med. 2018 Apr;48(4):765-785. doi: 10.1007/s40279-018-0862-z.

    PMID: 29372481BACKGROUND
  • Oosthuyse T, Bosch AN. The effect of the menstrual cycle on exercise metabolism: implications for exercise performance in eumenorrhoeic women. Sports Med. 2010 Mar 1;40(3):207-27. doi: 10.2165/11317090-000000000-00000.

    PMID: 20199120BACKGROUND
  • Lowe DA, Baltgalvis KA, Greising SM. Mechanisms behind estrogen's beneficial effect on muscle strength in females. Exerc Sport Sci Rev. 2010 Apr;38(2):61-7. doi: 10.1097/JES.0b013e3181d496bc.

    PMID: 20335737BACKGROUND
  • Elliott-Sale KJ, McNulty KL, Ansdell P, Goodall S, Hicks KM, Thomas K, Swinton PA, Dolan E. The Effects of Oral Contraceptives on Exercise Performance in Women: A Systematic Review and Meta-analysis. Sports Med. 2020 Oct;50(10):1785-1812. doi: 10.1007/s40279-020-01317-5.

    PMID: 32666247BACKGROUND
  • Janse DE Jonge X, Thompson B, Han A. Methodological Recommendations for Menstrual Cycle Research in Sports and Exercise. Med Sci Sports Exerc. 2019 Dec;51(12):2610-2617. doi: 10.1249/MSS.0000000000002073.

    PMID: 31246715BACKGROUND
  • Elliott-Sale KJ, Minahan CL, de Jonge XAKJ, Ackerman KE, Sipila S, Constantini NW, Lebrun CM, Hackney AC. Methodological Considerations for Studies in Sport and Exercise Science with Women as Participants: A Working Guide for Standards of Practice for Research on Women. Sports Med. 2021 May;51(5):843-861. doi: 10.1007/s40279-021-01435-8. Epub 2021 Mar 16.

    PMID: 33725341BACKGROUND
  • Carmichael MA, Thomson RL, Moran LJ, Wycherley TP. The Impact of Menstrual Cycle Phase on Athletes' Performance: A Narrative Review. Int J Environ Res Public Health. 2021 Feb 9;18(4):1667. doi: 10.3390/ijerph18041667.

    PMID: 33572406BACKGROUND
  • Castanier C, Bougault V, Teulier C, Jaffre C, Schiano-Lomoriello S, Vibarel-Rebot N, Villemain A, Rieth N, Le-Scanff C, Buisson C, Collomp K. The Specificities of Elite Female Athletes: A Multidisciplinary Approach. Life (Basel). 2021 Jun 26;11(7):622. doi: 10.3390/life11070622.

    PMID: 34206866BACKGROUND
  • Bruinvels G, Burden RJ, McGregor AJ, Ackerman KE, Dooley M, Richards T, Pedlar C. Sport, exercise and the menstrual cycle: where is the research? Br J Sports Med. 2017 Mar;51(6):487-488. doi: 10.1136/bjsports-2016-096279. Epub 2016 Jun 6. No abstract available.

    PMID: 27267895BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum and plasma samples from venous blood will be retained for the measurement of estrogen and progesterone levels and for plasma osmolality assessment. No DNA will be extracted.

Study Officials

  • Analiza M. Silva, PhD

    Exercise and Health Laboratory, CIPER, Faculdade Motricidade Humana, Universidade de Lisboa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2026

First Posted

May 18, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

June 1, 2028

Last Updated

May 18, 2026

Record last verified: 2026-05

Locations